Search the Newsreel

Sino Biopharmaceutical's H1 net profit surges over 90% as out-licensing revenue jumps 21-fold

Lincoln (LNC) Quarterly Results: EPS Beats Its Estimate; Share Response: Shares Move 3.55% Lower in Latest Trading - Full Year Guidance

Why Regeneron (REGN) Is Up 5.4% After FDA Approves Pasatru For Ultra-Rare FOP Therapy

In August 2026, Regeneron Pharmaceuticals announced that the US FDA approved Pasatru (garetosmab-grts) to reduce new heterotopic ossification lesions and flare-ups in adults with fibrodysplasia ossificans progressiva, based on positive Phase 3 OPTIMA trial results. This approval adds a rare-disease monoclonal antibody to Regeneron's …

CSPC Pharmaceutical Profit More Than Doubles on Finished Drug Growth

Saranacentral Bajatama Cetak Laba Bersih Rp21,33 Miliar Semester I-2026

Xeris (XERS) Financial Results: EPS Does Not Reach the Reported Estimate in the Available Record; Price Move

Extra Space Storage declares $1.62 dividend for Q3 2025, payable Sept 30 to shareholders of record Sept 15.

Extra Space Storage Inc. (EXR) has declared a dividend of $1.62 per share for the third quarter of 2025. This dividend is scheduled to be paid on September 30, 2025, to shareholders who are on record by September 15, 2025. The company, which is …

Saranacentral Bajatama (BAJA) Lepas Dari Suspensi Saham, Tegaskan Kinerjanya Pulih

Telix Pharmaceuticals Limited 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:TLX) 2026-08-20

Regeneron (REGN) Stock Looks Undervalued On Expanded Cancer Collaboration News

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Regeneron Pharmaceuticals stock has delivered a 43.0% return over the past year, yet the …

CSPC Pharmaceutical Group: Revenue and profit soared on finished drug sales and licensing, with strong R&D and global deals

Glenmark Pharmaceuticals gains 1.4% after US FDA nod for Fluticasone nasal spray

Mirum Pharmaceuticals(MIRM.US) Officer Sells US$4 Million in Common Stock

A Mirum Pharmaceuticals officer recently sold common stock valued at approximately $4 million. This transaction indicates a significant insider sale at the company.

SPCX Stock Suffers First Post-IPO Drop: Locked-Up Shares And Missing Shorts Skewed Debut Run, Analyst Says

Amylyx Pharmaceuticals Announces Pricing of an Upsized $500 Million Underwritten Public Offering of Common Stock

Amylyx Pharmaceuticals has announced the pricing of an upsized underwritten public offering of 14,090,000 shares of its common stock at $35.50 per share, aiming to raise $500.2 million before deductions. The company plans to use the net proceeds for pre-commercial activities for avexitide, research …

Why Eton Pharmaceuticals Is Top of the Class Today

Hong Kong Stocks in Focus | Simcere Pharmaceutical (02096) rises over 5% in early trading as it releases interim results today, driven by strong growth in innovative drugs and business development revenue

Telix Pharmaceuticals (ASX:TLX) Shares Rise Today as H1 Revenue Climbs 22% to US$477 Million

Telix Pharmaceuticals (ASX:TLX) saw its shares rise as it reported a 22% increase in H1 2026 revenue to US$477 million, with a gross margin of 55%. Adjusted EBITDA surged by 146% to US$52 million, and the company achieved a profit after tax of US$38 …

Does UHS’s Debt-Funded Talkspace Deal Reshape the Bull Case For Its Digital Behavioral Health Pivot?

Universal Health Services (UHS) recently acquired Talkspace, funding it with significant debt. This move into digital behavioral health raises questions about the company's investment narrative, given the increased financial leverage and softening earnings forecasts. The article discusses the implications of this debt-funded acquisition on …

AST SpaceMobile (NASDAQ: ASTS) CTO adds 40,000 shares via option exercise

AST SpaceMobile's CTO, Huiwen Yao, exercised 40,000 AST LLC Incentive Equity Options on August 19, 2026, at an exercise price of $0.0641 per share, increasing direct ownership to 74,750 shares of Class A Common Stock. This transaction reduced his derivative position to 219,912 units. …

AST SpaceMobile (ASTS) grants CFO 75,000 RSUs with multi-year vesting

AST SpaceMobile, Inc. (ASTS) has granted its CFO and Chief Legal Officer, Andrew Martin Johnson, 75,000 restricted stock units (RSUs). These RSUs will vest in three equal installments over three years, starting from May 30, 2026, contingent on his continued service. Following this grant, …

Telix Pharmaceuticals delivers robust half-year earnings and pipeline progress

Telix Pharmaceuticals (ASX: TLX) reported robust half-year results, with revenue up 22% to US$477 million and adjusted EBITDA surging 146% to US$52 million. The company made significant progress in pipeline development, strategic collaborations, and global manufacturing expansion. Telix reaffirmed its FY26 revenue guidance of …

What's Going On With Eupraxia Pharmaceuticals Inc Stock Wednesday?

Regeneron (REGN) Results Review: Profit Per Share Clears Its Benchmark in the Current Update; Closing Reaction

Geospace delivers 4,000 Pioneer seismic nodes to Faraday Geophysics in repeat order

Geospace has delivered 4,000 Pioneer land seismic acquisition nodes to Faraday Geophysics, marking a repeat purchase that increases Faraday's owned fleet to 7,000 nodes. Faraday aims to further expand its inventory to 10,000 nodes by November 2026 and eventually build a 40,000-node fleet by …

Stocks to Watch Today, August 20, 2026: Fabtech Technologies, Susan Electricals, Indiqube Spaces, Ceigall India and Autoline Industries

PMV (PMVP) Latest Quarter: The Available Earnings Metric Delivers a Beat in the Latest Reading; Closing Move: The Stock Records a 3.23% Increase on the Day - Analyst Coverage Count

RXT INVESTOR REMINDER: Rackspace Technology, Inc. Investors Have Until September 28, 2026 To Contact Kirby McInerney LLP to Seek Lead Plaintiff Role

Kirby McInerney LLP reminds investors of Rackspace Technology, Inc. (NASDAQ: RXT) that they have until September 28, 2026, to seek the lead plaintiff role in a securities fraud class action lawsuit. The lawsuit alleges Rackspace made misleading statements regarding its enterprise AI efforts, declining …

Mirum Pharmaceuticals (MIRM) SVP exercises 40k options, sells shares

Jolanda Howe, SVP, Global Controller at Mirum Pharmaceuticals (MIRM), exercised 40,000 employee stock options at $6.27 per share and subsequently sold all 40,000 common shares at $100.00 per share on August 18, 2026. This transaction resulted in an approximate pre-tax spread of $3.75 million. …

Corvus (CRVS) Q2 2026 Results: The EPS Result Is Below Expectation; Market Response: The Stock Records a 3.84% Increase in the Current Update - Financial Health Score

Aurinia Pharmaceuticals (AUPH) Stock Still Looks Cheap After A 74% Gain

Telix 2026 Half-Year Results: Strong Commercial Execution and Momentum in Late-Stage Pipeline

Telix Pharmaceuticals Limited MELBOURNE, Australia and INDIANAPOLIS, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces its financial results for the period ended June 30, 2026. H1 2026 key results Group performance1: Double-digit revenue growth and gross …

Talkspace (TALK) Financial Results: EPS Comes in Below Forecast for the Current Session; Market Move: Shares End With Little Net Change for the Current Session - Gross Profit Margin

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Major Shareholder Group Walters Buys 4,335,000 Shares of Stock

Major shareholder Group Walters purchased 4,335,000 shares of Zentalis Pharmaceuticals (NASDAQ:ZNTL) stock for $15.17 million, increasing their position by 32.09% to 17.84 million shares. This transaction occurred on August 14th, with the stock bought at an average price of $3.50 per share. Despite the …

Certain Class A Common Stock of Space Exploration Technologies Corp. are subject to a Lock-Up Agreement Ending on 20-AUG-2026.

Certain Class A Common Stock of Space Exploration Technologies Corp. are under a lock-up agreement set to end on August 20, 2026. This lock-up period, initiated on June 11, 2026, spans 70 days and affects approximately 911.5 million Class A Common Stock, which will …

Jolanda Howe Sells 40,000 Shares of Mirum Pharmaceuticals (NASDAQ:MIRM) Stock

Jolanda Howe, SVP of Mirum Pharmaceuticals (NASDAQ:MIRM), sold 40,000 shares of the company's stock for $4 million on August 18th, reducing her stake by 96.91% to 1,274 shares. This sale follows several other transactions since June. The company's stock trades at $102.24 with a …